Table 1 Demographics characteristics stratified by the BRAF and CTNNB1 mutations status in the primary patients and recurrent patients
From: Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach
|  | BRAF Mutant N = 12 | CTNNB1 Mutant N = 22 | Not Detected N = 10 | P Value | |||
|---|---|---|---|---|---|---|---|
Dataset | PP(N = 9) | RP(N = 3) | PP(N = 15) | RP(N = 7) | PP(N = 8) | RP(N = 2) | 1.000 |
Gender | Â | Â | Â | 0.770 | |||
 Male (%) | 9 (75.0) | 14 (63.6) | 6 (60.0) |  | |||
7 | 2 | 12 | 2 | 5 | 1 | Â | |
 Female (%) | 3 (25.0) | 8 (36.4) | 4 (40.0) |  | |||
2 | 1 | 3 | 5 | 3 | 1 | Â | |
Age(year) | Â | Â | Â | 0.002 | |||
 Mean ± SD | 47.0 ± 9.9 | 37.9 ± 15.9 | 24.9 ± 18.8 |  | |||
49.7 ± 8.65 | 39.0 ± 10.8 | 39.8 ± 15.9 | 33.9 ± 16.3 | 28.0 ± 19.9 | 12.5 ± 6.4 |  | |
 >18 (%) | 12 (100.0) | 19 (86.4) | 4 (40.0) |  | |||
9 | 3 | 13 | 6 | 4 | 0 | Â | |
 <18 (%) | 0 (0.0) | 3 (13.6) | 6 (60.0) |  | |||
0 | 0 | 2 | 1 | 4 | 2 | Â | |
Pathology | Â | Â | Â | <0.001 | |||
 ACP (%) | 0 (0.0) | 18 (81.8) | 8 (80.0) |  | |||
0 | 0 | 13 | 5 | 6 | 2 | Â | |
 PCP (%) | 12 (100.0) | 4 (18.2) | 2 (20.0) |  | |||
9 | 3 | 2 | 2 | 2 | 0 | Â | |